Impact of Influenza and Pneumococcal Vaccines on HIV Persistence and Immune Dynamics during Suppressive Antiretroviral Therapy

Persons with HIV on antiretroviral therapy were enrolled in the clinical trial. Blood was collected at baseline and days 2,4,7,14 and 30 postimmunizations. Expression of immunological markers on T cell subsets were measured by flow cytometry.